Skip to main content
. 2011 Jul-Sep;3(3):211–215. doi: 10.4103/0974-777X.83524

Table 2.

Isolation of ESBL producers in relation to administration of 3GC to the patients and the presence of co-morbidities in the patients

graphic file with name JGID-3-211-g002.jpg